Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Balu

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Scientific Reports|September 9, 2021
Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteinsNhan H Nguyen, Fiona Y Glassman, Robert K Dingman, et al.
Cancer Immunology Research|January 6, 2018
Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell ResponsesGautam N Shenoy, Jenni Loyall, Orla Maguire, et al.
Plos One|September 22, 2011
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasisRichard B Bankert, Sathy V Balu-Iyer, Kunle Odunsi, et al.
Clinical & Translational Immunology|February 8, 2021
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platformGautam N Shenoy, Christopher J Greene, Maulasri Bhatta, et al.
Cancer Immunity|July 26, 2013
Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft modelSandra J Yokota, John G Facciponte, Raymond J Kelleher, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironmentsMaulasri Bhatta, Gautam N Shenoy, Jenni L Loyall, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Scientific Reports|September 9, 2021
Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteinsNhan H Nguyen, Fiona Y Glassman, Robert K Dingman, et al.
Cancer Immunology Research|January 6, 2018
Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell ResponsesGautam N Shenoy, Jenni Loyall, Orla Maguire, et al.
Plos One|September 22, 2011
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasisRichard B Bankert, Sathy V Balu-Iyer, Kunle Odunsi, et al.
Clinical & Translational Immunology|February 8, 2021
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platformGautam N Shenoy, Christopher J Greene, Maulasri Bhatta, et al.
Cancer Immunity|July 26, 2013
Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft modelSandra J Yokota, John G Facciponte, Raymond J Kelleher, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironmentsMaulasri Bhatta, Gautam N Shenoy, Jenni L Loyall, et al.
Pageof 8